GODLIVE DESRAVINES: Open Payments
NPI 1750072518 · ST AUGUSTINE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$334 in 15 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $334
Food & beverage: $334
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $67 |
| Otsuka America Pharmaceutical, Inc. | 2 | $56 |
| Alkermes, Inc. | 2 | $43 |
| Vanda Pharmaceuticals Inc. | 1 | $32 |
| Noven Therapeutics, LLC | 2 | $29 |
| Tris Pharma Inc | 1 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| Lundbeck LLC | 1 | $21 |
| Almatica Pharma LLC | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
Products named: REXULTI, VRAYLAR, ARISTADA, HETLIOZ, Xelstrym, Dyanavel XR, COBENFY, LOREEV XR.
Industry payments across FL — which companies pay providers there.
